KORU Medical appoints Andrew LaFrence as CFO, effective July 10, 2023

KORU Medical Systems, Inc.

Andrew LaFrence brings 39 years of finance/accounting experience; previously CFO at Vyant Bio and Surmodics, 26 years at KPMG.
Base salary of $350k per year; eligible for annual cash bonus up to 50% of base salary.
Inducement option to purchase 300,000 shares of common stock, vesting 25% annually over 4 years.
Tom Adams, interim CFO, will continue as VP of Financial Planning and Analysis.
LaFrence will support the Vision 2026 growth strategy and scaling of the business.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Thomas Adams

Vice President of Financial Planning and Analysis

KRMD · KORU Medical Systems, Inc.

Effective: 2023-07-10
Successor: Andrew D. C. LaFrence
Filed: June 27, 2023, 7:59 PM ET

Thomas Adams, Interim Chief Financial Officer, will continue as the Company’s Vice President of Financial Planning and Analysis upon the appointment of Mr. LaFrence.

Appointed

Andrew D. C. LaFrence

Chief Financial Officer

KRMD · KORU Medical Systems, Inc.

Effective: 2023-07-10
Filed: June 27, 2023, 7:59 PM ET

Andrew D. C. LaFrence has been employed by KORU Medical Systems, Inc. (the “Company”) to serve as its Chief Financial Officer commencing July 10, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas Adams changed role as Vice President of Financial Planning and Analysis at KORU Medical Systems, Inc..

Action: role change
Role: Vice President of Financial Planning and Analysis

Exact text from the filing

Thomas Adams, Interim Chief Financial Officer, will continue as the Company’s Vice President of Financial Planning and Analysis upon the appointment of Mr. LaFrence.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew D. C. LaFrence was appointed as Chief Financial Officer at KORU Medical Systems, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

Andrew D. C. LaFrence has been employed by KORU Medical Systems, Inc. (the “Company”) to serve as its Chief Financial Officer commencing July 10, 2023.

View on SEC.gov

KORU Medical Systems, Inc. filing history →

Source: SEC EDGAR

accession 0001161697-23-000378

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.